
Elon Musk will proceed with his legal battle against OpenAI, according to his attorney Marc Toberoff, despite a newly proposed plan from the artificial intelligence firm to maintain control under its non-profit parent organization.
The announcement from Musk’s legal team came just hours after OpenAI revealed changes to its governance structure aimed at addressing criticism of its increasing commercial entanglements. Per Reuters, the revised plan would allow the non-profit board to retain control over the for-profit subsidiary and hold a significant ownership stake.
However, Musk’s team remains unconvinced. Toberoff criticized the updated framework, calling it insufficient and opaque. “Nothing in today’s announcement changes the fact that OpenAI will still be developing closed-source AI for the benefit of Altman, his investors, and Microsoft,” he stated, arguing that the revisions fail to address fundamental concerns about transparency and influence.
Read more: OpenAI Eyes Chrome If DOJ Forces Google to Sell Browser, Exec Testifies
According to Reuters, Musk originally co-founded OpenAI with a mission to develop artificial intelligence in a transparent and non-commercial manner. His lawsuit accuses the company of straying from that vision, particularly under the leadership of CEO Sam Altman and through partnerships with major investors like Microsoft.
OpenAI, in response, dismissed Musk’s claims. “Elon continuing with his baseless lawsuit only proves that it was always a bad-faith attempt to slow us down,” a spokesperson for the company said, according to Reuters.
Source: Reuters
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas